174 related articles for article (PubMed ID: 28373972)
1.
Schmidt R; Knappe D; Wende E; Ostorházi E; Hoffmann R
Front Chem; 2017; 5():15. PubMed ID: 28373972
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal binding and antibacterial activity of ethylene glycol-bridged apidaecin Api137 and oncocin Onc112 conjugates.
Goldbach T; Knappe D; Reinsdorf C; Berg T; Hoffmann R
J Pept Sci; 2016 Sep; 22(9):592-9. PubMed ID: 27406684
[TBL] [Abstract][Full Text] [Related]
3. Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.
Berthold N; Czihal P; Fritsche S; Sauer U; Schiffer G; Knappe D; Alber G; Hoffmann R
Antimicrob Agents Chemother; 2013 Jan; 57(1):402-9. PubMed ID: 23114765
[TBL] [Abstract][Full Text] [Related]
4. Continuous Subcutaneous Delivery of Proline-Rich Antimicrobial Peptide Api137 Provides Superior Efficacy to Intravenous Administration in a Mouse Infection Model.
Knappe D; Schmidt R; Adermann K; Hoffmann R
Front Microbiol; 2019; 10():2283. PubMed ID: 31632382
[TBL] [Abstract][Full Text] [Related]
5. Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88.
Lauer SM; Reepmeyer M; Berendes O; Klepacki D; Gasse J; Gabrielli S; Grubmüller H; Bock LV; Krizsan A; Nikolay R; Spahn CMT; Hoffmann R
Nat Commun; 2024 May; 15(1):3945. PubMed ID: 38730238
[TBL] [Abstract][Full Text] [Related]
6. Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa.
Holfeld L; Knappe D; Hoffmann R
J Antimicrob Chemother; 2018 Apr; 73(4):933-941. PubMed ID: 29309652
[TBL] [Abstract][Full Text] [Related]
7. Identification of Api88 Binding Partners in Escherichia coli Using a Photoaffinity-Cross-Link Strategy and Label-Free Quantification.
Volke D; Krizsan A; Berthold N; Knappe D; Hoffmann R
J Proteome Res; 2015 Aug; 14(8):3274-83. PubMed ID: 26196380
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake of apidaecin 1b and related analogs in Gram-negative bacteria reveals novel antibacterial mechanism for proline-rich antimicrobial peptides.
Berthold N; Hoffmann R
Protein Pept Lett; 2014 Apr; 21(4):391-8. PubMed ID: 24164266
[TBL] [Abstract][Full Text] [Related]
9. Oncocin Onc72 is efficacious against antibiotic-susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model.
Knappe D; Adermann K; Hoffmann R
Biopolymers; 2015 Nov; 104(6):707-11. PubMed ID: 25968331
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives.
Schmidt R; Ostorházi E; Wende E; Knappe D; Hoffmann R
J Antimicrob Chemother; 2016 Apr; 71(4):1003-11. PubMed ID: 26832757
[TBL] [Abstract][Full Text] [Related]
11. Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strain.
Krieger AK; Knappe D; Öhlmann S; Mayer L; Eder IB; Köller G; Hoffmann R; Rieckmann K; Baums CG
J Glob Antimicrob Resist; 2021 Mar; 24():127-135. PubMed ID: 33373733
[TBL] [Abstract][Full Text] [Related]
12. Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens.
Czihal P; Knappe D; Fritsche S; Zahn M; Berthold N; Piantavigna S; Müller U; Van Dorpe S; Herth N; Binas A; Köhler G; De Spiegeleer B; Martin LL; Nolte O; Sträter N; Alber G; Hoffmann R
ACS Chem Biol; 2012 Jul; 7(7):1281-91. PubMed ID: 22594381
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of optimized apidaecin and oncocin peptides against a multiresistant, KPC-producing Klebsiella pneumoniae strain.
Ostorhazi E; Nemes-Nikodem É; Knappe D; Hoffmann R
Protein Pept Lett; 2014 Apr; 21(4):368-73. PubMed ID: 24164263
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Antimicrobial Peptides Targeting the Protein Synthesis Machinery.
Graf M; Wilson DN
Adv Exp Med Biol; 2019; 1117():73-89. PubMed ID: 30980354
[TBL] [Abstract][Full Text] [Related]
15. Short Proline-Rich Antimicrobial Peptides Inhibit Either the Bacterial 70S Ribosome or the Assembly of its Large 50S Subunit.
Krizsan A; Prahl C; Goldbach T; Knappe D; Hoffmann R
Chembiochem; 2015 Nov; 16(16):2304-8. PubMed ID: 26448548
[TBL] [Abstract][Full Text] [Related]
16. Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model.
Knappe D; Fritsche S; Alber G; Köhler G; Hoffmann R; Müller U
J Antimicrob Chemother; 2012 Oct; 67(10):2445-51. PubMed ID: 22729924
[TBL] [Abstract][Full Text] [Related]
17. Identification of New Resistance Mechanisms in Escherichia coli against Apidaecin 1b Using Quantitative Gel- and LC-MS-Based Proteomics.
Schmidt R; Krizsan A; Volke D; Knappe D; Hoffmann R
J Proteome Res; 2016 Aug; 15(8):2607-17. PubMed ID: 27405093
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and pharmacokinetics of short, proline-rich antimicrobial peptides.
Holfeld L; Herth N; Singer D; Hoffmann R; Knappe D
Future Med Chem; 2015 Aug; 7(12):1581-96. PubMed ID: 26308283
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
Bluhm ME; Knappe D; Hoffmann R
Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
[TBL] [Abstract][Full Text] [Related]
20. Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells.
Keitel U; Schilling E; Knappe D; Al-Mekhlafi M; Petersen F; Hoffmann R; Hauschildt S
Innate Immun; 2013; 19(4):355-67. PubMed ID: 23112010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
